Slingshot members are tracking this event:
Allergan Files Application to FDA for Approval of Oculeve Intranasal Tear Neurostimulator
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Jul 18, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Oculeve Intranasal Tear Neurostimulator, Dry Eye Disease